Knowledge Hub

Biologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Press Release   •   Nov 30, 2016 05:08 EST has recently announced the addition of a market study “ Biologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 ”, is a comparative analysis of the global market.

Global Biologics Market: Scope and Methodology

This report provides forecast and analysis of the global biologics market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook for biologics revenue annually. It includes drivers and restraints of the global biologics market and their impact on each region during the forecast period. The report also comprises the study of applications and opportunities for biologics manufacturers. It also includes a detailed analysis by product type and supply chain analysis with a list of suppliers and industry stakeholders at each node in the supply chain.

In order to provide users of this report with a comprehensive view of the market, we have included detailed competitiveness analysis, key blockbuster products, clinical pipeline analysis and company players with unique propositions. The dashboard provides a comprehensive comparison of biologics manufacturers on parameters such as revenue sales, ranking of global players, strategic consolidations, i.e. mergers & acquisitions, licensing activities, as well as R&D activities. The study encompasses market attractiveness analysis, product type, application type, and region.

Global Biologics Market: Segmentation

The report includes the revenue generated from sales of biologics in all regions and important countries in these regions. By product, the global biologics market has been segmented into monoclonal antibodies, vaccines, recombinant hormones/vaccines, cell therapy, gene therapy and other products. By application type, the market is segmented into oncology, infectious diseases, immunology, auto-immune diseases, and other diseases. Furthermore, the global market is sub-segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Market numbers have been estimated based on the annual global and regional sales of key companies; annual production and the revenue of local players is derived from regional pricing trends. Market size and forecast for each segment have been provided in the context of global and regional markets. The global biologics market has been analyzed based on expected demand. Prices considered for the calculation of revenue are regional average prices obtained through primary quotes from numerous regional biologics manufacturers, suppliers, and distributors. All key end users have been considered, and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents. Regional demand patterns have been taken into consideration while assessing the market for various products manufactured in different regions. Top-down approach has been used to estimate the biologics market by regions. Market numbers for global product type and application segments have been derived using the bottom-up approach, which is cumulative of each region’s demand. The company-level market share has been calculated on the basis of revenues reported by key manufacturers. The market has been forecast based on constant currency rates.

Download The sample Copy Of This Report:

Several primary and secondary sources were consulted during the course of the study. Secondary sources include Factiva, World Bank, FDA, NCBI, Springer Journals, Google Books, Society Publications, Biotechnology Innovation Organization, Arthritis Foundation, British Society for Rheumatology and Hoover’s, as well as company annual reports and publications.

Global Biologics Market: Competitive Landscape

The report provides detailed competitive and company profiles of key participants operating in the global market. Key players in the global biologics market include AbbVie Inc., Amgen Inc, AstraZeneca, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sanofi.

The market has been segmented as below:

Global Biologics Market – By Product

Monoclonal Antibodies


Recombinant Hormones/Proteins

Cell Therapy

Gene Therapy


Global Biologics Market – By Applications


Infectious Diseases


Autoimmune Diseases


Global Biologics Market – By Region

North America



Latin America



Rest of Latin America







Rest of Europe

Asia Pacific (APAC)





New Zealand

Rest of Asia Pacific

Middle East and Africa (MEA)

Saudi Arabia



Rest of MEA

Table Of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Biologics Market

4. Market Overview

4.1. Introduction

4.1.1. Product Definition


4.3. Market Opportunity Map

4.4. Market Dynamics

4.4.1. Drivers

4.4.2. Restraints

4.4.3. Opportunity

4.5. Global Biologics Market Analysis and Forecasts, 2014–2024

4.5.1. Porter’s Analysis

4.5.2. Supply Chain Analysis Product Manufacturers Product Distributors End Users

4.5.3. Market Revenue Projections (US$ Mn)

4.9. Market Outlook

5. Global Biologics Market Analysis and Forecasts, By Product

5.1. Introduction & Definition

5.2. Key Findings / Developments

5.3. Global Biologics Market Value Share Analysis

5.4. Market Value Forecast By Product , 2014–2024

5.4.1. Monoclonal Antibodies

5.4.2. Vaccines

5.4.3. Recombinant Hormones/Proteins

5.4.4. Cell Therapy

5.4.5. Gene Therapy

5.4.6. Others

5.5. Market Attractiveness By Product

6. Global Biologics Market Analysis and Forecasts, By Application

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Biologics Market Value Share Analysis

6.4. Market Value Forecast By Application , 2014–2024

6.4.1. Oncology

6.4.2. Infectious Diseases

6.4.3. Immunology

6.4.4. Autoimmune Diseases

6.4.5. Others

6.5. Market Attractiveness By Application